Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (alliance)

Journal:

Journal of the National Cancer Institute

Published:

2025-09-25

DOI:

10.1093/jnci/djaf281

Affiliations:

15

Authors:

17

Go to article

Institutions	Authors	Share
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	3.000000	0.18
Albert Einstein College of Medicine (Einstein), United States of America (USA)	2.500000	0.15
Montefiore Medical Center, Einstein, United States of America (USA)	1.500000	0.09
Mayo Clinic, United States of America (USA)	1.000000	0.06
Barbara Ann Karmanos Cancer Institute, Wayne State University, United States of America (USA)	1.000000	0.06
The University of Chicago (UChicago), United States of America (USA)	1.000000	0.06
CHU de Québec, UL, Canada	1.000000	0.06
Columbus NCI Community Clinical Oncology Research Program (NCORP), United States of America (USA)	1.000000	0.06
Illinois CancerCare, United States of America (USA)	1.000000	0.06
Barnes-Jewish Hospital, United States of America (USA)	1.000000	0.06
Cleveland Clinic, United States of America (USA)	1.000000	0.06
AdventHealth, United States of America (USA)	1.000000	0.06
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	0.500000	0.03
Weill Cornell Medicine, United States of America (USA)	0.500000	0.03

Interested in Oncology and Carcinogenesis?